Medpace Holdings
Stock
Stock
ISIN: US58506Q1094
Ticker: MEDP
US58506Q1094
MEDP
Price
Price
CHART BY
Frequently asked questions
What is Medpace Holdings's market capitalization?
The market capitalization of Medpace Holdings is $10.48B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Medpace Holdings's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Medpace Holdings is 29.53. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Medpace Holdings?
Medpace Holdings's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $11.42. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Medpace Holdings's stock?
Currently, 11 analysts cover Medpace Holdings's stock, with a consensus target price of $354.75. Analyst ratings provide insights into the stock's expected performance.
What is Medpace Holdings's revenue over the trailing twelve months?
Over the trailing twelve months, Medpace Holdings reported a revenue of $2.07B.
What is the EBITDA for Medpace Holdings?
Medpace Holdings's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $437.53M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Medpace Holdings?
Medpace Holdings has a free cash flow of $535.65M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Medpace Holdings have, and what sector and industry does it belong to?
Medpace Holdings employs approximately 5,900 people. It operates in the Health Care sector, specifically within the Miscellaneous Commercial Services industry.
What is the free float of Medpace Holdings's shares?
The free float of Medpace Holdings is 25.49M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $10.48B
- EPS (TTM)
- $11.42
- Free Float
- 25.49M
- P/E ratio (TTM)
- 29.53
- Revenue (TTM)
- $2.07B
- EBITDA (TTM)
- $437.53M
- Free Cashflow (TTM)
- $535.65M
Pricing
- 1D span
- $328.89$342.58
- 52W span
- $279.09$457.94
Analyst Ratings
The price target is $354.75 and the stock is covered by 11 analysts.
Buy
5
Hold
5
Sell
1
Information
Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.
- Employees
- 5,900
- Industries
- Miscellaneous Commercial Services
- Sector
- Health Care
Identifier
- ISIN
- US58506Q1094
- Primary Ticker
- MEDP